« Previous
Next »
Cancer Letters
Volume 226, Issue 1
, Pages 65-75
, 8 August 2005
Cytotoxicity of three cycloartane triterpenoids from Cimicifuga dahurica
References
- Dictionary of Chinese spermatophyte, Science publishing house, 1984, 111.
- . Studies on the triterpenoid constituents from the aerial part of Cimicifuga foetida. Acta Pharm. Sinica. 2002;37:117–120
- . Chemical constituents of original plants of Cimicifugae rhizoma in Chinese medicine. Yakugaku Zasshi. 1996;116:850–865
- . Review of alternative therapies for treatment of menopausal symptoms. Climacteric. 2003;6:278–284
- . Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause. 2004;11:11–33
- D.H. Chen, J.Y. Si, X.H. Zhao, L.G. Shen, Triterpene compositions for hormonal disorder treatment, Chinese Patent, AN 2001:624328.
- . Cimicifuga racemosa extract inhibits proliferation of estrogen receptor-positive and negative human breast carcinoma cell lines by induction of apoptosis. Breast Cancer Res. Treat. 2004;84:151–160
- Growth inhibitory activity of extracts and purified components of black cohosh on human breast cancer cells. Breast Cancer Res. Treat. 2004;83:221–231
- . Four new cycloartane glycosides from Aquilegia vulgaris and their immunosuppressive activities in mouse allogeneic mixed lymphocyte reaction. Chem. Pharm. Bull. (Tokyo). 2003;51:683–687
- . Immunostimulatory effects of cycloartane-type triterpene glycosides from astragalus species. Biol. Pharm. Bull. 2000;23:834–837
- . Cytotoxic cycloartanes from Aglaia argentea. Phytochemistry. 1996;41:1325–1328
- . Argenteanones C-E and argenteanols B-E, cytotoxic cycloartanes from Aglaia argentea. J. Nat. Prod. 1997;60:81–85
- Antitumor agents 220. Antitumor-promoting effects of cimigenol and related compounds on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis. Bioorg. Med. Chem. 2003;11:1137–1140
- . Studies on the constituents of Cimicifuga species. XVIII. Four new xylosides from the aerial parts of cimicifuga simples WORMSK. Chem. Pharm. Bull. 1996;44:167–172
- . Two new cyclolanstanol xylosides from the aerial parts of Cimicifuga dahurica. J. Nat. Prod. 2002;65:1486–1488
- . Circumvention of multidrug resistance and reduction of cardiotoxicity of doxorubicin in vivo by coupling it with low density lipoprotein. Life Sci. 2002;72:677–687
- . Protective action of ursolic acid against chemical induced hepato-toxicity in rats. Ind. J. Pharmacol. 1996;28:232–239
- . Preparation of isolated rat liver cells. Meth. Cell Biol. 1976;13:30–83
- . Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity. Cancer Res. 1987;47:936–942
- . Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Dev. Res. 1995;34:91–109
- . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.). 1970;227:680–685
- . Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl Acad. Sci. USA. 1979;76:4350–4354
- . Induction of G2/M phase arrest and apoptosis by a new synthetic anti-cancer agent, DW2282, in promyelocytic leukemia (HL-60) cells. Biochem. Pharmacol. 2001;62:1439–1447
- . Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Cancer Res. 2000;60:2399–2404
- . Plant-derived triterpenoids as potential antineoplastic agents. Mini Rev. Med. Chem. 2003;3:540–556
- . Synthesis and biological activity of a platinum(II) 6-phenyl-2-2′-bipyridine complex and its dimeric analogue. Chem. Biochem. 2003;4:62–68
- . Cells in cryptophycin-induced cell-cycle arrest are susceptible to apoptosis. Cancer Lett. 2000;151:25–29
- . Induction of cell cycle arrest and apoptosis by a novel retinobenzoic-acid derivative, TAC-101, in human pancreatic-cancer cells. Int. J. Cancer. 1999;81:637–644
- . Molecular mechanisms involved in the antiproliferative effect of two COX-2 inhibitors, nimesulide and NS-398, on colorectal cancer cell lines. Dig. Liver Dis. 2003;35:557–565
- . Universal control mechanism regulating onset of M-phase. Nature. 1990;343:503–508
- Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res. 1996;56:4424–4429
- Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effects. Proc. Natl Acad. Sci. USA. 1996;93:4816–4820
- A selective cyclooxygenase-2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells. Gastroenterology. 1997;113:1883–1891
PII: S0304-3835(04)00876-6
doi: 10.1016/j.canlet.2004.11.019
© 2004 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Cancer Letters
Volume 226, Issue 1
, Pages 65-75
, 8 August 2005
